Literature DB >> 24483297

Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma.

Yinlong Yang1, Chengze Chen, Zimiao Chen, Jiachun Jiang, Yizuo Chen, Langping Jin, Guilong Guo, Xiaohua Zhang, Tingting Ye.   

Abstract

OBJECTIVES: We aimed to determine the predictive factors for central compartment lymph node metastasis (LNM) in papillary thyroid microcarcinoma (PTMC). DESIGN AND PATIENTS: We undertook a retrospective study of 291 patients treated for PTMC. The following criteria were assessed to predict the presence of central compartment LNM: sex, age, tumour multifocality, tumour size, tumour bilaterality, extracapsular spread (ECS), lateral neck LNM, coexistence of chronic lymphocytic thyroiditis, BRAF(V) (600E) mutation and ultrasonography (US) features. Univariate and multivariate analyses were performed to identify clinicopathological characteristics and US findings in predicting central compartment LNM from PTMC.
RESULTS: The central compartment LNM affected 133 (45.7%) of 291 patients. With use of univariate and multivariate analyses, male gender (OR 2.020; P = 0.039), tumour size (>5 mm) (OR 3.687; P = 0.015), ESC (OR 2.330; P = 0.044), lateral LNM (OR 15.075; P = 0.000) and BRAF(V) (600E) mutation (OR 2.464; P = 0.000) were independently correlated with central compartment LNM. Age, tumour multifocality, tumour bilaterality, coexistence of chronic lymphocytic thyroiditis and US characteristics were not significantly related to the presence of central compartment LNM. We have also developed a nomogram to predict the probability of central compartment LNM for an individual patient. The sensitivity was 71.9% and specificity was 70.3%, with an under the receiver operating characteristic (ROC) curve of 0.772.
CONCLUSIONS: A prophylactic neck dissection of the central compartment should be considered particularly in PTMC patients with male gender, a >5 mm tumour size, ECS of the tumours, lateral LNM and positive BRAF(V) (600E) mutation.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24483297     DOI: 10.1111/cen.12417

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  34 in total

1.  Clinical and sonographic assessment of cervical lymph node metastasis in papillary thyroid carcinoma.

Authors:  Qi Wu; Yi-Min Zhang; Si Sun; Juan-Juan Li; Juan Wu; Xiang Li; Shan Zhu; Wen Wei; Sheng-Rong Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

Review 2.  The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Liang-Sen Liu; Jia Liang; Jun-Hong Li; Xue Liu; Li Jiang; Jian-Xiong Long; Yue-Ming Jiang; Zhi-Xiao Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-19       Impact factor: 2.503

3.  Value of Ultrasound Combined with Immunohistochemistry Evaluation of Central Lymph Node Metastasis for the Prognosis of Papillary Thyroid Carcinoma.

Authors:  Xiaohua Yao; Ying Meng; Runsheng Guo; Guofeng Lu; Lin Jin; Yingchun Wang; Debin Yang
Journal:  Cancer Manag Res       Date:  2020-09-22       Impact factor: 3.989

4.  Machine Learning-Based Shear Wave Elastography Elastic Index (SWEEI) in Predicting Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Comparative Analysis of Five Practical Prediction Models.

Authors:  Xue Huang; Yukun Zhang; Du He; Lin Lai; Jun Chen; Tao Zhang; Huilin Mao
Journal:  Cancer Manag Res       Date:  2022-09-21       Impact factor: 3.602

Review 5.  The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma.

Authors:  Roberto Vita; Antonio Ieni; Giovanni Tuccari; Salvatore Benvenga
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

6.  Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.

Authors:  Patricia Aragon Han; Hyun-seok Kim; Soonweng Cho; Roghayeh Fazeli; Alireza Najafian; Hunain Khawaja; Melissa McAlexander; Benzon Dy; Meredith Sorensen; Anna Aronova; Thomas J Sebo; Thomas J Giordano; Thomas J Fahey; Geoffrey B Thompson; Paul G Gauger; Helina Somervell; Justin A Bishop; James R Eshleman; Eric B Schneider; Kenneth W Witwer; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2016-03-07       Impact factor: 6.568

7.  Evaluation of clinical risk factors for predicting insidious right central and posterior right recurrent laryngeal nerve lymph node metastasis in papillary thyroid microcarcinoma patients (cN0): experience of a single center.

Authors:  Fuqiang Li; Yijun Wu; Liang Chen; Liang Hu; Xiaosun Liu
Journal:  Ann Transl Med       Date:  2019-01

Review 8.  Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Wei Sun; Xiabin Lan; Hao Zhang; Wenwu Dong; Zhihong Wang; Liang He; Ting Zhang; Siming Liu
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

9.  The Utility of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma with Occult Lymph Nodes.

Authors:  Xingqiang Yan; Ruichao Zeng; Zhaosheng Ma; Chengze Chen; Endong Chen; Xiaohua Zhang; Feilin Cao
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

10.  Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.

Authors:  Vivian Y Park; Eun-Kyung Kim; Hye Sun Lee; Hee Jung Moon; Jung Hyun Yoon; Jin Young Kwak
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.